Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
A Phase 3, Multicenter, Open-Label, Randomized, Comparator Controlled Trial of the Safety and Efficacy of Dalbavancin Versus Active Comparator in Pediatric Subjects With Acute Bacterial Skin and Skin Structure Infections

To determine the safety and descriptive efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections in children, aged birth to 17 years (inclusive), known or

platelet count
staphylococcus aureus
antibiotic therapy
tenderness
MRSA
  • 18 views
  • 27 Oct, 2022
  • 10 locations
Study to Optimize the Use of New Antibiotics (NEW_SAFE)

patients who have received either empirical or targeted treatment with ceftaroline, tedizolid, dalbavancin, ceftazidime-avibactam, ceftolozane-tazobactam and isavuconazole from January 2016 to December

antibiotics
antibiotic therapy
vancomycin
dalbavancin
isavuconazole
  • 3 views
  • 16 Feb, 2022
  • 13 locations
Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections

Because of its prolonged terminal half-life, dalbavancin is an extremely attractive option in treating Gram-positive infections caused by S. aureus including MRSA, and streptococcal species

antibiotics
MRSA
staphylococcus aureus
vancomycin
bacterial infections
  • 228 views
  • 26 Feb, 2022
  • 1 location
  • 12 views
  • 25 Oct, 2022
  • 18 locations
Evaluation of Intravenous Dalbavancin for Peritonitis

This study evaluates the use of Dalbavancin 1500 mg IV x 1 dose for treating patients with gram positive peritonitis in patients requiring peritoneal dialysis.

  • 0 views
  • 12 Mar, 2022
  • 1 location